These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3670879)
1. Cerebrospinal fluid and plasma pharmacokinetics of morphine infusions in pediatric cancer patients and rhesus monkeys. Greene RF; Miser AW; Lester CM; Balis FM; Poplack DG Pain; 1987 Sep; 30(3):339-348. PubMed ID: 3670879 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606 [TBL] [Abstract][Full Text] [Related]
3. Age-dependent morphine partitioning between plasma and cerebrospinal fluid in monkeys. Lynn AM; McRorie TI; Slattery JT; Calkins DF; Opheim KE Dev Pharmacol Ther; 1991; 17(3-4):200-4. PubMed ID: 1841838 [TBL] [Abstract][Full Text] [Related]
4. Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry. Sadiq MW; Salehpour M; Forsgard N; Possnert G; Hammarlund-Udenaes M Drug Metab Dispos; 2011 Feb; 39(2):174-9. PubMed ID: 21059857 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of distribution of morphine and metabolites in cerebrospinal fluid and plasma with chronic intrathecal morphine infusion in humans. Wallace M; Yaksh TL Anesth Analg; 2012 Oct; 115(4):797-804. PubMed ID: 22822192 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala2-D-Leu5-enkephalin. Moulin DE; Inturrisi CE; Foley KM Ann Neurol; 1986 Aug; 20(2):218-22. PubMed ID: 3530119 [TBL] [Abstract][Full Text] [Related]
8. The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates. Meany HJ; Fox E; McCully C; Tucker C; Balis FM Cancer Chemother Pharmacol; 2008 Aug; 62(3):387-92. PubMed ID: 17932674 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of epidural morphine in man. Nordberg G; Hedner T; Mellstrand T; Borg L Eur J Clin Pharmacol; 1984; 26(2):233-7. PubMed ID: 6723763 [TBL] [Abstract][Full Text] [Related]
10. Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates. Patel M; McCully C; Godwin K; Balis FM J Neurooncol; 2003 Feb; 61(3):203-7. PubMed ID: 12675312 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of morphine in cerebrospinal fluid and plasma after epidural administration in man. Drost RH; Ionescu TI; Taverne RH; van Lingen G; van Rossum JM; Maes RA Arzneimittelforschung; 1988 Nov; 38(11):1632-4. PubMed ID: 3214449 [TBL] [Abstract][Full Text] [Related]
12. Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates. Warren KE; McCully C; Dvinge H; Tjørnelund J; Sehested M; Lichenstein HS; Balis FM Cancer Chemother Pharmacol; 2008 Aug; 62(3):433-7. PubMed ID: 17960383 [TBL] [Abstract][Full Text] [Related]
13. Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates. Shah NN; Cole DE; Lester-McCully CM; Wayne AS; Warren KE; Widemann BC Invest New Drugs; 2016 Feb; 34(1):61-5. PubMed ID: 26661090 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of morphine in infant monkeys. Lynn AM; McRorie TI; Slattery JT; Calkins D; Opheim KE Dev Pharmacol Ther; 1991; 16(1):41-7. PubMed ID: 1879251 [TBL] [Abstract][Full Text] [Related]
15. Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients. Wolff T; Samuelsson H; Hedner T Pain; 1996 Dec; 68(2-3):209-16. PubMed ID: 9121807 [TBL] [Abstract][Full Text] [Related]
16. The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model. Widemann BC; Balis FM; Godwin KS; McCully C; Adamson PC Cancer Chemother Pharmacol; 1999; 44(6):439-43. PubMed ID: 10550563 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of CPT-11 in rhesus monkeys. Inaba M; Ohnishi Y; Ishii H; Tanioka Y; Yoshida Y; Sudoh K; Hakusui H; Mizuno N; Ito K; Sugiyama Y Cancer Chemother Pharmacol; 1998; 41(2):103-8. PubMed ID: 9443622 [TBL] [Abstract][Full Text] [Related]
18. CSF and plasma pharmacokinetics of intramuscular morphine. Nordberg G; Borg L; Hedner T; Mellstrand T Eur J Clin Pharmacol; 1985; 27(6):677-81. PubMed ID: 3987773 [TBL] [Abstract][Full Text] [Related]
19. Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine. The influence of renal failure. D'Honneur G; Gilton A; Sandouk P; Scherrmann JM; Duvaldestin P Anesthesiology; 1994 Jul; 81(1):87-93. PubMed ID: 8042814 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries. Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]